The FDA has begun publishing reports of adverse events concerning drugs and biological products on a daily basis ...

Hey, good morning. Today, we see CBER suspend the license for a chikungunya vaccine, look at a push to recall a safety and ...

Good morning. For all our talk about potato chips in this newsletter, nobody has ever attempted to give a STAT reporter a wad ...

Amid demand for retraction, a leading medical journal is reviewing a discredited study published in 2001 that touted the ...

Rather than thinking in terms of single targets or isolated therapeutic classes, we now have the opportunity and imperative ...

After an M.D./Ph.D. started using testosterone, he felt incredible — until he realized his lab results showed something alarming.

"That is so brilliant. Why didn’t we think of this before?" As MAHA turns 1, STAT examines the growth of the movement and ...